(14 Aug 2020) Tocilizumab- post TCZ complications seen in 61% patients
Late Onset Infectious Complications and Safety of Tocilizumab in the Management of COVID-19 https://doi.org/10.1002/jmv.26429 Seventy-four patients were included in each group. Seven-teen infections in the TCZ group (23%) and 6 (8%) infections in the control group occurred >48 hours after… Continue reading "(14 Aug 2020) Tocilizumab- post TCZ complications seen in 61% patients"